✦ LIBER ✦

Triplet combination of gemcitabine, carboplatin, and paclitaxel in previously treated, relapsed ovarian and peritoneal carcinoma: an experience in Taiwan

✍ Scribed by Fu-Shing Liu; Esther Shih-Chu Ho; Man-Jung Hung; Sheau-Feng Hwang; Chien-Hsing Lu; Yu-Min Ke

Book ID: 113959350
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 91 KB
Volume: 94
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2004.05.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Triplet combination of gemcitabine, pacl

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma

✍ Swan Swan Leong; Joseph Wee; Sandeep Rajan; Chee Keong Toh; Wan Teck Lim; Siew W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

A phase I study of intraperitoneal carbo

A phase I study of intraperitoneal carboplatin with intravenous paclitaxel and bevacizumab in patients with previously untreated epithelial ovarian carcinoma or primary peritoneal carcinoma

✍ O’Malley, D.; Eisenhauer, E.; McCann, G.; Salani, R.; Backes, F.; Copeland, L.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Phase I feasibility trial of carboplatin

Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study

✍ Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Gemcitabine and cisplatin chemotherapy i

Gemcitabine and cisplatin chemotherapy is an active combination in the treatment of platinum-resistant ovarian and peritoneal carcinoma

✍ Devansu Tewari; Bradley J. Monk; Mark Hunter; Camille A. Falkner; Robert A. Burg 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 110 KB

Prognostic significance of p53 mutation

Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin

✍ Yuko Ueno; Takayuki Enomoto; Yoshiro Otsuki; Nagatoshi Sugita; Ryuichi Nakashima 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Phase I trial of autologous hematopoieti

Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma

✍ Litzow, M R; Peethambaram, P P; Safgren, S L; Keeney, G L; Ansell, S M; Dispenzi 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 189 KB